0000899866-17-000161.txt : 20170905 0000899866-17-000161.hdr.sgml : 20170905 20170905192816 ACCESSION NUMBER: 0000899866-17-000161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170831 FILED AS OF DATE: 20170905 DATE AS OF CHANGE: 20170905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Julie CENTRAL INDEX KEY: 0001630299 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 171069966 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 2032722596 MAIL ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 wf-form4_150465408293648.xml FORM 4 X0306 4 2017-08-31 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001630299 O'Neill Julie C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510 0 1 0 0 EVP. Global Operations Common Stock, par value $.0001 per share 2017-08-31 4 S 0 612 142 D 26092 D Common Stock, par value $.0001 per share 2017-09-05 4 S 0 1841 145.81 D 24251 D Common Stock, par value $.0001 per share 2017-09-05 4 S 0 672 147 D 23579 D Common Stock, par value $.0001 per share 2017-09-05 4 S 0 600 145.64 D 22979 D Common Stock, par value $.0001 per share 2017-09-05 4 S 0 650 145.81 D 22329 D The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $142.00 - $142.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $145.51 - $146.51. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units. /s/ Michael Greco, Attorney-in-Fact for Julie O'Neill 2017-09-05